About LevitasBio
LevitasBio is a company based in San Francisco (United States) founded in 2017 by Lars Steinmetz, Gozde Durmus, and Utkan Demirci.. LevitasBio has raised $73.77 million across 4 funding rounds from investors including Novalis LifeSciences, Pavilion Capital Partners and Decheng Capital. LevitasBio offers products and services including LeviCell EOS, LeviCell 1.0, LeviPrep, LeviSelect, and LeviMetrics. LevitasBio operates in a competitive market with competitors including 10X Genomics, Mission Bio, Cellares, LUMICKS and Biolog, among others.
- Headquarter San Francisco, United States
- Founders Lars Steinmetz, Gozde Durmus, Utkan Demirci
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$73.77 M (USD)
in 4 rounds
-
Latest Funding Round
$11.76 M (USD), Series C
Mar 28, 2024
-
Investors
Novalis LifeSciences
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LevitasBio
LevitasBio offers a comprehensive portfolio of products and services, including LeviCell EOS, LeviCell 1.0, LeviPrep, LeviSelect, and LeviMetrics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Processes samples to improve cell viability and remove debris.
Elevates research by isolating viable cells from low-quality samples.
Handles primary tissues for better dissociation and integrity.
Enriches specific cells without altering their state.
Analyzes levitated samples using AI-based tools.
Unlock access to complete
Unlock access to complete
Funding Insights of LevitasBio
LevitasBio has successfully raised a total of $73.77M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $11.76 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series C — $11.8M
-
First Round
First Round
(03 Aug 2017)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Series C - LevitasBio | Valuation |
investors |
|
| Oct, 2022 | Amount | Series C - LevitasBio | Valuation | Novalis LifeSciences | |
| Jan, 2021 | Amount | Series B - LevitasBio | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in LevitasBio
LevitasBio has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Novalis LifeSciences, Pavilion Capital Partners and Decheng Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment and advisory services are provided for life sciences.
|
Founded Year | Domain | Location | |
|
Growth-stage companies are invested in by this venture capital fund.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on life science and technology sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by LevitasBio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - LevitasBio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Levitasbio Comparisons
Competitors of LevitasBio
LevitasBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, Mission Bio, Cellares, LUMICKS and Biolog, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Instrument systems for genomic research and sequencing libraries are developed.
|
|
| domain | founded_year | HQ Location |
Single-cell multi-omics platform is provided for genotypic and phenotypic analysis.
|
|
| domain | founded_year | HQ Location |
Medical devices for cell-based therapy manufacturing are produced.
|
|
| domain | founded_year | HQ Location |
Optical tweezers instruments for single-molecule analysis are manufactured.
|
|
| domain | founded_year | HQ Location |
Cell-based phenotyping technologies and assays are provided for microbial analysis.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Levitasbio
Frequently Asked Questions about LevitasBio
When was LevitasBio founded?
LevitasBio was founded in 2017.
Where is LevitasBio located?
LevitasBio is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of LevitasBio?
Martin Pieprzyk is the current CEO of LevitasBio.
Is LevitasBio a funded company?
LevitasBio is a funded company, having raised a total of $73.77M across 4 funding rounds to date. The company's 1st funding round was a Series B of $19.01M, raised on Aug 03, 2017.
What does LevitasBio do?
Founded in 2017 and based in San Francisco, United States, LevitasBio operates in the biotechnology sector. A single-cell imaging and profiling platform, known as the levitation image cytometry platform, is being developed using magnetic levitation technology. This label-free method for cell analysis is intended for applications in therapeutics, diagnostics, and research. The platform enables universal cell profiling without traditional labeling techniques.
Who are the top competitors of LevitasBio?
LevitasBio's top competitors include 10X Genomics, Mission Bio and Cellares.
What products or services does LevitasBio offer?
LevitasBio offers LeviCell EOS, LeviCell 1.0, LeviPrep, LeviSelect, and LeviMetrics.
Who are LevitasBio's investors?
LevitasBio has 3 investors. Key investors include Novalis LifeSciences, Pavilion Capital Partners, and Decheng Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.